Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
The non-invasive evaluation of liver steatosis and fibrosis with FibroScan is a routinely procedure in clinical practice for people with obesity. However, there are still considerable uncertainties regarding the potential influence of confounding factors and the optimal application of cut-off values for obesity. The goal of this observational study is to learn about the optimal application of cut-off values of for Chinese people with obesity.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
View:
• Patients aged 18 years or older who provided written informed consent
• Patients who schedule to undergo bariatric surgery and a liver biopsy (LB) for the investigation of suspected MASLD
• Patients who schedule to undergo FibroScan examination
Locations
Other Locations
China
The Third People's Hospital of Chengdu
RECRUITING
Chengdu
Contact Information
Primary
Peisen Guo
peisenguo@163.com
+8615803838681
Time Frame
Start Date: 2023-10-24
Estimated Completion Date: 2025-03-31
Participants
Target number of participants: 600
Related Therapeutic Areas
Sponsors
Leads: The Third People's Hospital of Chengdu